| TRAW |
Traws Pharma, Inc. |
Common Stock |
20% |
$1,164,061 |
|
760,824 |
|
ORBIMED ADVISORS LLC |
31 Dec 2024 |
| EWTX |
Edgewise Therapeutics, Inc. |
Common Stock |
14% |
$234,894,152 |
|
15,252,867 |
|
ORBIMED ADVISORS LLC |
09 May 2025 |
| ELVN |
Enliven Therapeutics, Inc. |
COMMON STOCK |
13% |
$140,468,212 |
|
7,918,163 |
|
ORBIMED ADVISORS LLC |
16 Jun 2025 |
| CRVS |
CORVUS PHARMACEUTICALS, INC. |
Common stock, par value $0.0001 per share (the "Shares"). |
12% |
$35,423,231 |
|
9,785,423 |
0% |
ORBIMED ADVISORS LLC |
12 May 2025 |
| STTK |
Shattuck Labs, Inc. |
Common Stock, par value $0.0001 per share |
10% |
$5,107,963 |
|
6,306,127 |
|
ORBIMED ADVISORS LLC |
25 Aug 2025 |
| ACET |
Adicet Bio, Inc. |
Common Stock, par value $0.0001 |
9.6% |
$11,974,668 |
|
14,772,598 |
|
ORBIMED ADVISORS LLC |
08 Oct 2025 |
| PMVP |
PMV Pharmaceuticals, Inc. |
COMMON STOCK |
9.4% |
$6,965,407 |
|
4,975,291 |
|
ORBIMED ADVISORS LLC |
23 Oct 2025 |
| MBX |
MBX Biosciences, Inc. |
COMMON STOCK |
9% |
$55,600,100 |
|
4,002,887 |
|
ORBIMED ADVISORS LLC |
26 Sep 2025 |
| CMPX |
Compass Therapeutics, Inc. |
COMMON STOCK |
8.9% |
$41,093,984 |
|
15,219,994 |
0% |
ORBIMED ADVISORS LLC |
13 Aug 2025 |
| WHWK |
Whitehawk Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
8.9% |
$6,415,640 |
|
4,166,000 |
|
OrbiMed Advisors LLC |
31 Mar 2025 |
| AVTX |
Avalo Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
8.9% |
$4,622,260 |
|
967,000 |
|
OrbiMed Advisors LLC |
30 Jun 2025 |
| SION |
Sionna Therapeutics, Inc. |
Common Stock |
8.4% |
$44,607,706 |
|
3,704,959 |
|
ORBIMED ADVISORS LLC |
10 Feb 2025 |
| NPCE |
NeuroPace Inc |
Common Stock, par value $0.001 per share |
8% |
$26,716,960 |
-$8,095,783 |
2,614,184 |
-23% |
OrbiMed Advisors LLC |
30 Jun 2025 |
| FBRX |
Forte Biosciences, Inc. |
Common Stock, par value $0.001 per share |
8% |
$3,763,800 |
|
510,000 |
|
ORBIMED ADVISORS LLC |
31 Dec 2024 |
| AVBP |
ArriVent BioPharma, Inc. |
Common Stock |
7.5% |
$66,692,036 |
|
3,027,328 |
|
ORBIMED ADVISORS LLC |
11 Aug 2025 |
| IKNA |
ImageneBio, Inc. |
COMMON STOCK |
6.9% |
$820,179 |
-$7,669,269 |
773,754 |
-90% |
ORBIMED ADVISORS LLC |
25 Jul 2025 |
| RAPT |
RAPT Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.6% |
$28,023,878 |
-$310,734,477 |
1,086,618 |
-92% |
ORBIMED ADVISORS LLC |
30 Sep 2025 |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
Common Stock, par value $0.0001 per share |
5.9% |
$5,307,498 |
|
718,200 |
|
OrbiMed Capital LLC |
31 Dec 2024 |
| CTMX |
CytomX Therapeutics, Inc. |
Common Stock, par value $0.00001 per share |
5.4% |
$20,984,520 |
|
8,461,500 |
|
OrbiMed Advisors LLC |
30 Jun 2025 |
| VTGN |
Vistagen Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
5.3% |
$5,820,935 |
|
1,639,700 |
|
ORBIMED CAPITAL LLC |
30 Sep 2025 |
| CCCC |
C4 Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
5% |
$7,921,728 |
-$2,413,704 |
3,568,346 |
-23% |
OrbiMed Capital LLC |
30 Sep 2025 |
| TERN |
Terns Pharmaceuticals, Inc. |
Common Stock |
4.8% |
$31,842,911 |
|
4,240,068 |
|
ORBIMED ADVISORS LLC |
03 Nov 2025 |
| IRON |
Disc Medicine, Inc. |
Common Stock |
4.5% |
$73,382,798 |
|
1,556,369 |
|
ORBIMED ADVISORS LLC |
10 Mar 2025 |
| PASG |
Passage BIO, Inc. |
COMMON STOCK |
4.2% |
$53,029 |
-$44,595 |
132,473 |
-46% |
ORBIMED ADVISORS LLC |
22 Jul 2025 |
| NSPR |
InspireMD, Inc. |
Common Stock, par value $0.0001 per share |
4.1% |
$5,141,506 |
|
2,133,405 |
0% |
OrbiMed Advisors LLC |
30 Sep 2025 |
| ADCT |
ADC Therapeutics SA |
Common Shares, par value CHF 0.08 per share |
3.6% |
$5,019,207 |
|
3,437,813 |
|
ORBIMED CAPITAL LLC |
31 Dec 2024 |
| VSTM |
Verastem, Inc. |
Common Stock, par value $0.0001 per share |
2.4% |
$6,319,998 |
-$7,248,005 |
1,333,333 |
-53% |
ORBIMED ADVISORS LLC |
30 Jun 2025 |
| XFOR |
X4 Pharmaceuticals, Inc |
Common Stock, par value $0.001 per share |
1.7% |
$25,640 |
|
134,947 |
|
ORBIMED ADVISORS LLC |
30 Jun 2025 |
| XTNT |
Xtant Medical Holdings, Inc. |
COMMON STOCK |
0% |
$0 |
|
0 |
|
ORBIMED ADVISORS LLC |
10 Apr 2025 |